You are here

Business Wire

All our partners

BUSINESS WIRE helps companies to disseminate their full text press releases, regulatory information and multimedia documents effectively and securely to news agencies, journalists, analysts and investors the world over.

https://www.businesswire.com
11/11/2019 - 18:00

ZMC Partners With CommentSold

CommentSold, Inc. (“CommentSold” or the “Company”) today announced that affiliates of private equity firm ZMC have invested in the Company. Terms of the transaction were not disclosed. Founded in 2017 by CEO Brandon Kruse, CommentSold is a leading provider of multi-channel social commerce technology and managed services to boutique online retailers. The Company provides a variety of commerce...

CommentSold, Inc. (“CommentSold” or the “Company”) today announced that affiliates of private equity firm ZMC have invested in the Company. Terms of the transaction were not disclosed. Founded in 2017 by CEO Brandon Kruse, CommentSold is a leading provider of multi-channel social commerce technology and managed services to boutique online retailers. The Company provides a variety of commerce...


11/11/2019 - 18:00

GA-ASI to Conduct Series of Capability Demonstrations in Europe

General Atomics Aeronautical Systems, Inc. (GA-ASI), a global leader in Remotely Piloted Aircraft (RPA), announced today that they are working with the Hellenic Air Force (HAF) in Greece to conduct a series of demonstration flights for European countries in December. Flights will base out of the HAF’s site in Larissa and use a GA-ASI MQ-9 Guardian RPA to showcase maritime surveillance capabili...

General Atomics Aeronautical Systems, Inc. (GA-ASI), a global leader in Remotely Piloted Aircraft (RPA), announced today that they are working with the Hellenic Air Force (HAF) in Greece to conduct a series of demonstration flights for European countries in December. Flights will base out of the HAF’s site in Larissa and use a GA-ASI MQ-9 Guardian RPA to showcase maritime surveillance capabili...


11/11/2019 - 17:00

aBey Blockchain Co-Creator Dr. Ciprian Pungila Delivers Keynote Address on Opening Day of Malta Blockchain Summit 2019

The aBey Foundation today released the full text and video of Dr. Ciprian Pungila’s keynote address during the opening session of the Malta Blockchain Summit 2019. Dr. Pungila is co-creator of aBey blockchain technology and serves as chief scientist of the non-profit aBey Foundation. The Malta Blockchain Summit ran November 7-8. This press release features multimedia. View the full release her...

The aBey Foundation today released the full text and video of Dr. Ciprian Pungila’s keynote address during the opening session of the Malta Blockchain Summit 2019. Dr. Pungila is co-creator of aBey blockchain technology and serves as chief scientist of the non-profit aBey Foundation. The Malta Blockchain Summit ran November 7-8. This press release features multimedia. View the full release her...


11/11/2019 - 15:20

Novarica Market Navigator Report Validates FINEOS is the Market Leader in Life, Accident and Health Claims Systems in North America By Client Base

FINEOS Corporation (ASX: FCL), the leading core insurance platform vendor for life, accident and health (LA&H), was profiled in the recent Novarica Market Navigator Life/Health Claims Systems (September 2019). The report shows FINEOS has the largest client base for LA&H Claims in North America covering both individual and group markets. The Novarica Market Navigator report provides an ...

FINEOS Corporation (ASX: FCL), the leading core insurance platform vendor for life, accident and health (LA&H), was profiled in the recent Novarica Market Navigator Life/Health Claims Systems (September 2019). The report shows FINEOS has the largest client base for LA&H Claims in North America covering both individual and group markets. The Novarica Market Navigator report provides an ...


11/11/2019 - 14:30

The New 2020 Report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Gives Highest Evidence Rating to Endobronchial Valves, including the Zephyr Valve, for Treatment of Emphysema / COPD

Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that the 2020 update from the Global Initiative for Chronic Obstructive Disease (GOLD) has upgraded the evidence level rating for bronchoscopic lung volume reduction (BLVR) with endobronchial valves, including the Zephyr Valve, for the treatment of emphysema / chronic obstructive pulmonary disease (COPD...

Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that the 2020 update from the Global Initiative for Chronic Obstructive Disease (GOLD) has upgraded the evidence level rating for bronchoscopic lung volume reduction (BLVR) with endobronchial valves, including the Zephyr Valve, for the treatment of emphysema / chronic obstructive pulmonary disease (COPD...


11/11/2019 - 14:26

TREMFYA®▼ (guselkumab), a First-in-Class IL-23 p19 Subunit Inhibitor, Meets Primary Endpoints of Superior ACR20 Responses versus Placebo at Week 24 in Phase 3 Psoriatic Arthritis Studies

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced 24-week Phase 3 data showing a significantly greater proportion of patients with active psoriatic arthritis (PsA) treated with TREMFYA®▼ (guselkumab) achieved at least a 20 percent improvement in disease signs and symptoms (American College of Rheumatology ACR20 response) compared to placebo.1,2 These findings repres...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced 24-week Phase 3 data showing a significantly greater proportion of patients with active psoriatic arthritis (PsA) treated with TREMFYA®▼ (guselkumab) achieved at least a 20 percent improvement in disease signs and symptoms (American College of Rheumatology ACR20 response) compared to placebo.1,2 These findings repres...


11/11/2019 - 13:55

Wipro Implements SAP S/4HANA® for Sydney Water

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced the successful implementation of SAP S/4HANA® software for Sydney Water, a statutory state-owned corporation wholly owned by the New South Wales Government. Wipro has also integrated modules of Industry-Specific Solution for the Utilitie...

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced the successful implementation of SAP S/4HANA® software for Sydney Water, a statutory state-owned corporation wholly owned by the New South Wales Government. Wipro has also integrated modules of Industry-Specific Solution for the Utilitie...


11/11/2019 - 13:30

Verrency Appoints Dickson Chu to Global Advisory Board

Global payment innovation company Verrency today announced the appointment of Dickson Chu, an accomplished payments executive and business builder, to its global advisory board. Mr. Chu has held leadership roles at prominent companies including Paypal, Wells Fargo, Yahoo!, Living Social and Citi, and is a board director and active advisor to a number of emerging payment companies. He is curr...

Global payment innovation company Verrency today announced the appointment of Dickson Chu, an accomplished payments executive and business builder, to its global advisory board. Mr. Chu has held leadership roles at prominent companies including Paypal, Wells Fargo, Yahoo!, Living Social and Citi, and is a board director and active advisor to a number of emerging payment companies. He is curr...


11/11/2019 - 11:34

Foley Hoag Leads The Gambia’s Legal Team in Historic Case to Stop Myanmar’s Genocide Against the Rohingya

The Gambia, acting on behalf of the 57 Member States of the Organization of Islamic Cooperation, today filed a historic lawsuit in the International Court of Justice, in The Hague, seeking to hold Myanmar accountable under international law for State-sponsored genocide against its minority Muslim population, known as the Rohingya. The suit also asks the Court to order Myanmar to cease and desi...

The Gambia, acting on behalf of the 57 Member States of the Organization of Islamic Cooperation, today filed a historic lawsuit in the International Court of Justice, in The Hague, seeking to hold Myanmar accountable under international law for State-sponsored genocide against its minority Muslim population, known as the Rohingya. The suit also asks the Court to order Myanmar to cease and desi...


11/11/2019 - 10:00

myPOS Welcomes New Chief Strategy Officer Jean Beaubois

European payment service provider myPOS is delighted to announce the appointment of new Chief Strategy Officer, Jean Beaubois, effective 11th of November 2019. Jean Beaubois comes from SafeCharge, an international payment technology company, where he was in charge of Investor Relations and M&A for the last two years. Jean brings extensive experience and knowledge in payment technology, f...

European payment service provider myPOS is delighted to announce the appointment of new Chief Strategy Officer, Jean Beaubois, effective 11th of November 2019. Jean Beaubois comes from SafeCharge, an international payment technology company, where he was in charge of Investor Relations and M&A for the last two years. Jean brings extensive experience and knowledge in payment technology, f...

11/12/2019 - 19:30

Michael Buckley to Return to True Religion Apparel as Chief Executive Officer

True Religion Apparel, Inc., announced that the Board of Directors has appointed Michael Buckley as its new Chief Executive Officer, effective immediately. Mr. Buckley was previously President of True Religion Apparel from 2006 to 2010. He will be responsible for developing and implementing the future vision and roadmap for True Religion. Mr. Buckley will report to the Board of Directors of th...

True Religion Apparel, Inc., announced that the Board of Directors has appointed Michael Buckley as its new Chief Executive Officer, effective immediately. Mr. Buckley was previously President of True Religion Apparel from 2006 to 2010. He will be responsible for developing and implementing the future vision and roadmap for True Religion. Mr. Buckley will report to the Board of Directors of th...


11/12/2019 - 17:08

Bempedoic Acid Significantly Reduces LDL-Cholesterol on Top of Statin Therapy: Results of the CLEAR Wisdom Trial, Published in the Journal of the American Medical Association

Daiichi Sankyo Europe GmbH (hereafter, ‘Daiichi Sankyo’) today announced the publication of results from the Phase 3 CLEAR Wisdom trial in the Journal of the American Medical Association (JAMA).1 Bempedoic acid is currently undergoing review for marketing authorisation by the European Medicines Agency (EMA) and by the United States Food and Drug Administration (FDA). CLEAR Wisdom, a Phase 3,...

Daiichi Sankyo Europe GmbH (hereafter, ‘Daiichi Sankyo’) today announced the publication of results from the Phase 3 CLEAR Wisdom trial in the Journal of the American Medical Association (JAMA).1 Bempedoic acid is currently undergoing review for marketing authorisation by the European Medicines Agency (EMA) and by the United States Food and Drug Administration (FDA). CLEAR Wisdom, a Phase 3,...


11/12/2019 - 16:57

 Vertex Confirms Northern Ireland Offer Accepted for Cystic Fibrosis Medicines

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirms that the Regional Pharmaceutical Procurement Service in Northern Ireland has accepted an offer for access to all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of these medicines under the same terms as the recently announced agreement with NHS England. This means that once the contract is ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirms that the Regional Pharmaceutical Procurement Service in Northern Ireland has accepted an offer for access to all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of these medicines under the same terms as the recently announced agreement with NHS England. This means that once the contract is ...


11/12/2019 - 15:30

Andersen Global Announces First Collaboration in Croatia

Andersen Global announced today that it signed a Collaboration Agreement with one of Croatia’s largest law firms, KALLAY & PARTNERS Ltd. The addition of the Zagreb-based firm establishes Andersen Global’s presence in the country and continues the expansion of the organization in the region. Founded in 2006, KALLAY & PARTNERS Ltd. is led by Founder and Office Managing Director Marko K...

Andersen Global announced today that it signed a Collaboration Agreement with one of Croatia’s largest law firms, KALLAY & PARTNERS Ltd. The addition of the Zagreb-based firm establishes Andersen Global’s presence in the country and continues the expansion of the organization in the region. Founded in 2006, KALLAY & PARTNERS Ltd. is led by Founder and Office Managing Director Marko K...


11/12/2019 - 15:03

New TNS Research Highlights Global Market Opportunity For Secure Commerce At The Pump

A new report being published today by Transaction Network Services (TNS) suggests that the majority of consumers are open to new experiences when they pay-at-the-pump which could provide significant revenue opportunities for retailers. The report called ‘The Market Opportunity for Secure Commerce at the Pump’ explores the findings of a survey* TNS commissioned among US, UK and Australian adu...

A new report being published today by Transaction Network Services (TNS) suggests that the majority of consumers are open to new experiences when they pay-at-the-pump which could provide significant revenue opportunities for retailers. The report called ‘The Market Opportunity for Secure Commerce at the Pump’ explores the findings of a survey* TNS commissioned among US, UK and Australian adu...


11/12/2019 - 15:00

Report: The Delivery Economy Uncovering Misalignment In the Supply Chain

The rapid growth of the Delivery Economy — the pervasive sentiment in which customers expect low-cost, fast and highly transparent delivery of goods — is pressuring companies to quickly address structural supply chain challenges that make it difficult for them to meet increasing customer demands, according to a new report from project44, the global leader in advanced visibility for shippers an...

The rapid growth of the Delivery Economy — the pervasive sentiment in which customers expect low-cost, fast and highly transparent delivery of goods — is pressuring companies to quickly address structural supply chain challenges that make it difficult for them to meet increasing customer demands, according to a new report from project44, the global leader in advanced visibility for shippers an...


11/12/2019 - 15:00

Modern Governance 8.0: New Report from Stanford’s Rock Center and Diligent Institute Reveals Corporate Directors Are Less Shareholder-Centric and Success Is No Longer Defined Solely by Shareholder Returns

In a new report released today, Diligent Institute and the Rock Center for Corporate Governance at Stanford University found that board directors consider both shareholder and stakeholder needs when making strategic decisions – reinforcing a stakeholder movement that embraces modern governance. The report, “Stakeholders Take Center Stage: Director Views on Priorities and Society,” includes res...

In a new report released today, Diligent Institute and the Rock Center for Corporate Governance at Stanford University found that board directors consider both shareholder and stakeholder needs when making strategic decisions – reinforcing a stakeholder movement that embraces modern governance. The report, “Stakeholders Take Center Stage: Director Views on Priorities and Society,” includes res...


11/12/2019 - 14:36

Boehringer Ingelheim and Lilly initiate first ever study to assess empagliflozin in people hospitalised for acute heart failure who have been stabilised

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the initiation of EMPULSE, the sixth Phase III study in the empagliflozin heart failure programme. The study will assess whether in-hospital administration of empagliflozin 10 mg daily improves heart failure outcomes when initiated in people hospitalised for any type of acute heart failure event once they have been stab...

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the initiation of EMPULSE, the sixth Phase III study in the empagliflozin heart failure programme. The study will assess whether in-hospital administration of empagliflozin 10 mg daily improves heart failure outcomes when initiated in people hospitalised for any type of acute heart failure event once they have been stab...


11/12/2019 - 14:30

Moody’s Analytics Wins Seven Categories, Finishes #4 in Chartis RiskTech100®

Moody’s Analytics, a global provider of financial intelligence, has won seven category awards in the Chartis RiskTech100® 2020, earning an overall ranking of #4 among the world’s top 100 providers of risk management technology for the second straight year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191112005360/en/ In addition ...

Moody’s Analytics, a global provider of financial intelligence, has won seven category awards in the Chartis RiskTech100® 2020, earning an overall ranking of #4 among the world’s top 100 providers of risk management technology for the second straight year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191112005360/en/ In addition ...


11/12/2019 - 14:28

Altasciences Welcomes Martin Poirier as Senior Director, Bioanalytical Sciences

Altasciences is pleased to announce the appointment of Martin Poirier, M.Sc., as Senior Director of Bioanalytical Sciences, based in Altasciences’ preclinical facility in Seattle, WA. Martin will apply his extensive knowledge and experience to guide internal and external clients throughout their bioanalysis and immunomodulation analysis projects. Martin’s outstanding industry reputation and ...

Altasciences is pleased to announce the appointment of Martin Poirier, M.Sc., as Senior Director of Bioanalytical Sciences, based in Altasciences’ preclinical facility in Seattle, WA. Martin will apply his extensive knowledge and experience to guide internal and external clients throughout their bioanalysis and immunomodulation analysis projects. Martin’s outstanding industry reputation and ...

11/13/2019 - 20:00

Juan Carro Arbelo Appointed as Regional Manager for Insurance, Iberia

Starr Insurance Companies today announced the appointment of Juan Carro Arbelo as Regional Manager for Insurance, Iberia, subject to regulatory approval. Mr. Carro is responsible for the development of Starr’s commercial lines presence across the Iberian Peninsula, effective November 4, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/...

Starr Insurance Companies today announced the appointment of Juan Carro Arbelo as Regional Manager for Insurance, Iberia, subject to regulatory approval. Mr. Carro is responsible for the development of Starr’s commercial lines presence across the Iberian Peninsula, effective November 4, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/...


11/13/2019 - 18:49

OneConnect Announces Public Filing of Registration Statement for Proposed Initial Public Offering

OneConnect Financial Technology Co., Ltd. (OneConnect), a leading technology-as-a-service platform for financial institutions in China, today announced that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its ordinary shares in the form of American Depositary Shares, or ADSs. OneConn...

OneConnect Financial Technology Co., Ltd. (OneConnect), a leading technology-as-a-service platform for financial institutions in China, today announced that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its ordinary shares in the form of American Depositary Shares, or ADSs. OneConn...


11/13/2019 - 18:00

SNCF Selects Klas Telecom TRX R6 for French National Rail Network

Klas Telecom today announced that, together with their French partner Seolane Innovation, they have entered into an agreement with France’s national rail operator, SNCF to supply the TRX R6 Connected Transportation Platform for implementation on board SNCF’s trains. This agreement comes as the result of a highly competitive public tender in which SNCF sought to acquire an onboard connectivity ...

Klas Telecom today announced that, together with their French partner Seolane Innovation, they have entered into an agreement with France’s national rail operator, SNCF to supply the TRX R6 Connected Transportation Platform for implementation on board SNCF’s trains. This agreement comes as the result of a highly competitive public tender in which SNCF sought to acquire an onboard connectivity ...


11/13/2019 - 17:17

U.S. Ambassador Johnson and UK’s Sir Nicholas Soames to join Bermuda Premier at Executive Forum in London

The United States Ambassador to the United Kingdom (UK), Robert Wood Johnson, and the UK’s Rt. Hon. Sir Nicholas Soames, former defence minister and former Conservative Member of Parliament for Mid Sussex, will join Bermuda’s Premier, the Hon. E. David Burt, JP, MP, at an Executive Forum in London this month to highlight the historic and successful economic relationship that exists between Ber...

The United States Ambassador to the United Kingdom (UK), Robert Wood Johnson, and the UK’s Rt. Hon. Sir Nicholas Soames, former defence minister and former Conservative Member of Parliament for Mid Sussex, will join Bermuda’s Premier, the Hon. E. David Burt, JP, MP, at an Executive Forum in London this month to highlight the historic and successful economic relationship that exists between Ber...


11/13/2019 - 17:01

Advance Auto Parts, Blue Cross NC, Emory Healthcare, Johnsonville, Parkview Health, and Royal Bank of Scotland Receive Planview Vision Awards

Over 700 attendees came together at Planview Horizons 2019 to connect, collaborate, and celebrate with their industry peers. This year, Advance Auto Parts, Blue Cross NC, Emory Healthcare, Johnsonville, Parkview Health, and Royal Bank of Scotland were the recipients of Planview Vision Awards for transformational leadership and excellence. “There are many remarkable business transformation jo...

Over 700 attendees came together at Planview Horizons 2019 to connect, collaborate, and celebrate with their industry peers. This year, Advance Auto Parts, Blue Cross NC, Emory Healthcare, Johnsonville, Parkview Health, and Royal Bank of Scotland were the recipients of Planview Vision Awards for transformational leadership and excellence. “There are many remarkable business transformation jo...


11/13/2019 - 15:00

Mercatus Selected as Finalist for REFI US Award for Portfolio Management

Mercatus, the data and technology platform for private market investors, today announced it has been shortlisted as a finalist for the 2019 REFI US Award for Portfolio Management. The REFI US Awards reward real estate private equity funds and service providers for outstanding performance and overall excellence. “We understand the unique challenges of real estate investing in harnessing very ...

Mercatus, the data and technology platform for private market investors, today announced it has been shortlisted as a finalist for the 2019 REFI US Award for Portfolio Management. The REFI US Awards reward real estate private equity funds and service providers for outstanding performance and overall excellence. “We understand the unique challenges of real estate investing in harnessing very ...


11/13/2019 - 15:00

CyberOptics Wins Global Technology Award for SQ3000™ Inspection and Metrology System at productronica Germany

CyberOptics® Corporation (NASDAQ: CYBE), a leading global developer and manufacturer of high-precision 3D sensing technology solutions, announced that it was awarded a 2019 Global Technology Award in the category of Inspection – AOI for its SQ3000™ Multi-Function for AOI, SPI and CMM. The award was presented to the company during a Tuesday, Nov. 12, 2019 ceremony that took place during product...

CyberOptics® Corporation (NASDAQ: CYBE), a leading global developer and manufacturer of high-precision 3D sensing technology solutions, announced that it was awarded a 2019 Global Technology Award in the category of Inspection – AOI for its SQ3000™ Multi-Function for AOI, SPI and CMM. The award was presented to the company during a Tuesday, Nov. 12, 2019 ceremony that took place during product...


11/13/2019 - 13:48

CHTF2019 Kicks off in Shenzhen, Gathering Global Exhibitors and Visitors

China’s No. 1 technology show – the 21st China Hi-Tech Fair (CHTF2019) – opened at the Shenzhen Convention and Exhibition Center on November 13, and will run till November 17. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191113005440/en/ Themed on "Invigorating the Greater Bay Area through Opening-up and Innovation," CHTF2019 is ...

China’s No. 1 technology show – the 21st China Hi-Tech Fair (CHTF2019) – opened at the Shenzhen Convention and Exhibition Center on November 13, and will run till November 17. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191113005440/en/ Themed on "Invigorating the Greater Bay Area through Opening-up and Innovation," CHTF2019 is ...


11/13/2019 - 13:15

ADVA unveils commercially ready disaggregated cell site gateway solution at TIP ’19

ADVA (FSE: ADV) today announced the commercial readiness of its disaggregated cell site gateway (DCSG) solution at the Telecom Infra Project (TIP) Summit. Powered by ADVA’s Ensemble Activator network operating system (NOS), the integrated white box solution comes with a comprehensive bundle of installation, commissioning and monitoring services for rapid network deployment. The technology is c...

ADVA (FSE: ADV) today announced the commercial readiness of its disaggregated cell site gateway (DCSG) solution at the Telecom Infra Project (TIP) Summit. Powered by ADVA’s Ensemble Activator network operating system (NOS), the integrated white box solution comes with a comprehensive bundle of installation, commissioning and monitoring services for rapid network deployment. The technology is c...


11/13/2019 - 13:00

GSMA Connected Society Innovation Fund Announces Winners

The GSMA today announced the winners of the Connected Society Innovation Fund for Rural Connectivity. Fairwaves Inc., iSat Africa and NuRAN, have been awarded grants of up to £330,000 to test and evaluate new innovative mobile internet connectivity solutions for unconnected rural communities in Africa. The fund will be allocated in partnership with Vodafone Ghana and MTN Uganda and is set to r...

The GSMA today announced the winners of the Connected Society Innovation Fund for Rural Connectivity. Fairwaves Inc., iSat Africa and NuRAN, have been awarded grants of up to £330,000 to test and evaluate new innovative mobile internet connectivity solutions for unconnected rural communities in Africa. The fund will be allocated in partnership with Vodafone Ghana and MTN Uganda and is set to r...

11/14/2019 - 17:28

Nahyan bin Mubarak Inaugurates World Tolerance Summit in Dubai

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Chairman of the Board of Trustees of the International Institute for Tolerance, IIT, officially opened on Thursday the second day of the second World Tolerance Summit (WTS), held this year under the theme ‘Tolerance in Multiculturalism: Achieving the Social, Economic and Humane Benefits of a Tolerant World'. Over 3,0...

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Chairman of the Board of Trustees of the International Institute for Tolerance, IIT, officially opened on Thursday the second day of the second World Tolerance Summit (WTS), held this year under the theme ‘Tolerance in Multiculturalism: Achieving the Social, Economic and Humane Benefits of a Tolerant World'. Over 3,0...


11/14/2019 - 15:59

Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock

To mark the five year anniversary of the study by Stretch, et al., on cost and outcomes trends for short-term mechanical circulatory support, Abiomed announces a comprehensive publication review of cost and comparative effectiveness of Impella in high-risk PCI and cardiogenic shock. The data, from a robust body of US and European evidence from 2004 - 2019, includes the PROTECT II FDA randomize...

To mark the five year anniversary of the study by Stretch, et al., on cost and outcomes trends for short-term mechanical circulatory support, Abiomed announces a comprehensive publication review of cost and comparative effectiveness of Impella in high-risk PCI and cardiogenic shock. The data, from a robust body of US and European evidence from 2004 - 2019, includes the PROTECT II FDA randomize...


11/14/2019 - 15:00

The International Board of Lactation Consultant Examiners (IBLCE) selects Prometric for Global Examination Administration

We are pleased to announce that the International Board of Lactation Consultant Examiners® (IBLCE®) has selected Prometric® as its partner for the global administration of the International Board Certified Lactation Consultant® (IBCLC®) credential. Under the terms of this multi-year agreement, IBCLC candidates will have access to Prometric’s secure computer-based testing (CBT) locations around...

We are pleased to announce that the International Board of Lactation Consultant Examiners® (IBLCE®) has selected Prometric® as its partner for the global administration of the International Board Certified Lactation Consultant® (IBCLC®) credential. Under the terms of this multi-year agreement, IBCLC candidates will have access to Prometric’s secure computer-based testing (CBT) locations around...


11/14/2019 - 14:30

Varex to Highlight Advanced Imaging Components at Medica in Dusseldorf

Varex Imaging Corporation (Nasdaq: VREX) today announced it will showcase its digital detectors, X-ray imaging tubes, connect and control devices and software solutions at Medica 2019. Medica is attended by leaders in the fields of business and research, and international experts and decision-makers from the medical sector covering the entire spectrum of innovations for outpatient and clinical...

Varex Imaging Corporation (Nasdaq: VREX) today announced it will showcase its digital detectors, X-ray imaging tubes, connect and control devices and software solutions at Medica 2019. Medica is attended by leaders in the fields of business and research, and international experts and decision-makers from the medical sector covering the entire spectrum of innovations for outpatient and clinical...


11/14/2019 - 14:00

Esri Joins Autodesk University 2019 Conference

Esri, the global leader in location intelligence, will take part in this year's Autodesk University Las Vegas conference, which will be held November 19–21, 2019, at the Las Vegas Sands Convention Center. Experts from Esri will be on-site to discuss how geographic information system (GIS) technology allows architecture, engineering, and construction (AEC) professionals to collect and analyze f...

Esri, the global leader in location intelligence, will take part in this year's Autodesk University Las Vegas conference, which will be held November 19–21, 2019, at the Las Vegas Sands Convention Center. Experts from Esri will be on-site to discuss how geographic information system (GIS) technology allows architecture, engineering, and construction (AEC) professionals to collect and analyze f...


11/14/2019 - 13:53

REPLY: The Board of Directors Approves the Quarterly Financial Report as of 30 September 2019

Today, the Board of Directors of Reply [MTA, STAR: REY] approved the results as at 30 September 2019. In the first nine months of the year, the Group has recorded a consolidated turnover of €866.2 million, which is an increase of 14.8% compared to €754.4 million at 30 September 2018. All indicators are positive for the period (*). Consolidated EBITDA to September 2019, was €136.2 million, ...

Today, the Board of Directors of Reply [MTA, STAR: REY] approved the results as at 30 September 2019. In the first nine months of the year, the Group has recorded a consolidated turnover of €866.2 million, which is an increase of 14.8% compared to €754.4 million at 30 September 2018. All indicators are positive for the period (*). Consolidated EBITDA to September 2019, was €136.2 million, ...


11/14/2019 - 12:59

GE Achieves Record Transmission of Power on a Super Energy Highway in India

GE’s Grid Solutions business (NYSE:GE) announced today a new milestone in its Champa-Kurukshetra ultra-high-voltage direct current (UHVDC) project in India with the 1,305-km link now capable of transmitting 4,500 MW of electricity. This follows the recent successful energization of the third of four poles planned for the ±800kV UHVDC transmission line. This press release features multimedia. V...

GE’s Grid Solutions business (NYSE:GE) announced today a new milestone in its Champa-Kurukshetra ultra-high-voltage direct current (UHVDC) project in India with the 1,305-km link now capable of transmitting 4,500 MW of electricity. This follows the recent successful energization of the third of four poles planned for the ±800kV UHVDC transmission line. This press release features multimedia. V...


11/14/2019 - 12:31

.ευ (.eu in Greek) Goes Live

The launch of the .eu in Greek represents another milestone in .eu history as well as in the ongoing campaign for supporting online multilingualism, following the introduction of the .eu in Cyrillic in June 2016. ‘The .eu in Greek will enable end-users to enjoy the full Internationalised Domain Names experience in Greek, as Greek domain names will be registered under the Greek extension. We ...

The launch of the .eu in Greek represents another milestone in .eu history as well as in the ongoing campaign for supporting online multilingualism, following the introduction of the .eu in Cyrillic in June 2016. ‘The .eu in Greek will enable end-users to enjoy the full Internationalised Domain Names experience in Greek, as Greek domain names will be registered under the Greek extension. We ...


11/14/2019 - 12:08

Alipay Aims to Help 10 Million European Merchants Reach Over 2 Billion Potential Consumers in Five Years With Innovative Technology

Alipay, the world’s leading payment and lifestyle platform, today announced a new target to support 10 million small and medium enterprises in Europe over the next five years, through innovative technology that will empower these merchants to better serve and sell to over 2 billion potential consumers travelling to the region from around the world. This press release features multimedia. View ...

Alipay, the world’s leading payment and lifestyle platform, today announced a new target to support 10 million small and medium enterprises in Europe over the next five years, through innovative technology that will empower these merchants to better serve and sell to over 2 billion potential consumers travelling to the region from around the world. This press release features multimedia. View ...


11/14/2019 - 12:00

Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced the approval of the Axonics r-SNM® System by the United States Food & Drug Administration (“FDA”) for the clinical indications of...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced the approval of the Axonics r-SNM® System by the United States Food & Drug Administration (“FDA”) for the clinical indications of...

11/08/2019 - 15:00

Workiva Hosts Amplify Europe User Conference

Workiva (NYSE:WK), provider of the world’s leading connected reporting and compliance platform, today announces that it will host a user conference, Amplify Europe, on 21 November at The Crystal here. Amplify Europe will bring together Workiva customers, partners and industry leaders for a full day of training, networking and professional development on global reporting and compliance. Glo...

Workiva (NYSE:WK), provider of the world’s leading connected reporting and compliance platform, today announces that it will host a user conference, Amplify Europe, on 21 November at The Crystal here. Amplify Europe will bring together Workiva customers, partners and industry leaders for a full day of training, networking and professional development on global reporting and compliance. Glo...


11/08/2019 - 14:00

Gilead Presents Data on Investigational HIV-1 Capsid Inhibitor GS-6207 as a Potential Component of Long-Acting HIV Therapy

Gilead Sciences, Inc. (NASDAQ:GILD) today announced data on GS-6207, an investigational, novel, selective, first-in-class inhibitor of HIV-1 capsid function, that support its further development and potential role as a component in long-acting HIV combination therapy. New data from two Phase 1 studies demonstrate that GS-6207 has potent antiviral activity and a potential dosing interval of up ...

Gilead Sciences, Inc. (NASDAQ:GILD) today announced data on GS-6207, an investigational, novel, selective, first-in-class inhibitor of HIV-1 capsid function, that support its further development and potential role as a component in long-acting HIV combination therapy. New data from two Phase 1 studies demonstrate that GS-6207 has potent antiviral activity and a potential dosing interval of up ...


11/08/2019 - 14:00

Gilead Announces New Data from Viral Hepatitis Research Programs at The Liver Meeting® 2019

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data on Vemlidy® (tenofovir alafenamide 25 mg, TAF) that continue to support an improved safety profile compared with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (HBV) infection. These results, along with new data from Gilead’s HBV cure and hepatitis C (HCV) research programs, are being presented at The Liver...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data on Vemlidy® (tenofovir alafenamide 25 mg, TAF) that continue to support an improved safety profile compared with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (HBV) infection. These results, along with new data from Gilead’s HBV cure and hepatitis C (HCV) research programs, are being presented at The Liver...


11/08/2019 - 14:00

Data Showing Potential for Machine Learning to Advance Understanding of Nonalcoholic Steatohepatitis (NASH) Presented at the Liver Meeting® 2019

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from the company’s nonalcoholic steatohepatitis (NASH) research and development program, including studies evaluating machine learning approaches to the interpretation of liver histology, noninvasive tests (NITs) for the characterization and monitoring of disease severity, and novel therapies for the treatment of this disease. The d...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from the company’s nonalcoholic steatohepatitis (NASH) research and development program, including studies evaluating machine learning approaches to the interpretation of liver histology, noninvasive tests (NITs) for the characterization and monitoring of disease severity, and novel therapies for the treatment of this disease. The d...


11/08/2019 - 13:58

New Analyses from the Phase 3 HELP Study™ Open-Label Extension in Hereditary Angioedema Evaluate Efficacy and Safety of TAKHZYRO® (lanadelumab-flyo) Injection During Extended Study Treatment Period

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data that further investigates the long-term safety and efficacy of TAKHZYRO® (lanadelumab-flyo) injection in patients with hereditary angioedema (HAE) 12 years of age and older studied in the ongoing Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Open-label Extension (OLE). The analyses...

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data that further investigates the long-term safety and efficacy of TAKHZYRO® (lanadelumab-flyo) injection in patients with hereditary angioedema (HAE) 12 years of age and older studied in the ongoing Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Open-label Extension (OLE). The analyses...


11/08/2019 - 13:07

HKSTP’s EPiC Competition 2019 Attracted Record Number of International Startups Vying for HK$1 Million Cash Prizes and Tapping into Greater Bay Area Opportunities

Hong Kong Science and Technology Parks Corporation (HKSTP) today concluded its annual Elevator Pitch Competition 2019 (EPiC), which saw 126 top-notch start-ups from 33 markets making the business pitch of their lives, vying for cash prizes of over HK$1 million. This is the fourth year of the competition, and this year's event attracted a record number of 650 applications in the first round of ...

Hong Kong Science and Technology Parks Corporation (HKSTP) today concluded its annual Elevator Pitch Competition 2019 (EPiC), which saw 126 top-notch start-ups from 33 markets making the business pitch of their lives, vying for cash prizes of over HK$1 million. This is the fourth year of the competition, and this year's event attracted a record number of 650 applications in the first round of ...


11/08/2019 - 13:00

F-star Presents New Data on OX40/CD137 Tetravalent Bispecific Antibody at the SITC 2019 Annual Meeting

F-star Therapeutics (“F-star”), a clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announces that new preclinical data on FS120, a mAb² product candidate targeting OX40 and CD137, will be presented at the Society for Immunotherapy of Cancer (SITC) 2019 Annual...

F-star Therapeutics (“F-star”), a clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announces that new preclinical data on FS120, a mAb² product candidate targeting OX40 and CD137, will be presented at the Society for Immunotherapy of Cancer (SITC) 2019 Annual...


11/08/2019 - 12:45

The Estée Lauder Companies Releases Fiscal 2019 Corporate Responsibility Report Highlighting Progress on Citizenship and Sustainability Goals

The Estée Lauder Companies Inc. (NYSE: EL) released its Fiscal 2019 Corporate Responsibility Report (CR Report). The report entitled, “Inspired by Beauty, Driven by Our Values,” underscores the company’s progress and commitment to strengthening efforts across core citizenship and sustainability focus areas and highlights key milestones demonstrating industry leadership in inclusion and diver...

The Estée Lauder Companies Inc. (NYSE: EL) released its Fiscal 2019 Corporate Responsibility Report (CR Report). The report entitled, “Inspired by Beauty, Driven by Our Values,” underscores the company’s progress and commitment to strengthening efforts across core citizenship and sustainability focus areas and highlights key milestones demonstrating industry leadership in inclusion and diver...


11/08/2019 - 10:19

RoboSense Wins CES 2020 Innovation Award for Autonomous Vehicle Technology

RoboSense http://www.robosense.ai, the world’s leading autonomous driving LiDAR perception solution provider, announced today that it has won the CES 2020 Innovation Award the second year in a row for autonomous vehicle technology. RoboSense won this year’s CES 2020 Innovation Award for the first MEMS-based Smart LiDAR Sensor, the RoboSense RS-LiDAR-M1, winning in the Vehicle Intelligence and ...

RoboSense http://www.robosense.ai, the world’s leading autonomous driving LiDAR perception solution provider, announced today that it has won the CES 2020 Innovation Award the second year in a row for autonomous vehicle technology. RoboSense won this year’s CES 2020 Innovation Award for the first MEMS-based Smart LiDAR Sensor, the RoboSense RS-LiDAR-M1, winning in the Vehicle Intelligence and ...


11/08/2019 - 10:07

Achiko Ltd.: Fintech Achiko Limited Lists its Shares on the SIX Swiss Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (AS A WHOLE OR IN PART) IN OR FOR THE USA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE THIS COULD CONSTITUTE A VIOLATION OF THE APPLICABLE LAWS UNDER THAT JURISDICTION Achiko Limited ("Achiko", ISIN KGY0101M1024), a leading provider of game payment services in Indonesia, today lists its 89'632'142 shares on the SIX Swiss Exchange at...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (AS A WHOLE OR IN PART) IN OR FOR THE USA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE THIS COULD CONSTITUTE A VIOLATION OF THE APPLICABLE LAWS UNDER THAT JURISDICTION Achiko Limited ("Achiko", ISIN KGY0101M1024), a leading provider of game payment services in Indonesia, today lists its 89'632'142 shares on the SIX Swiss Exchange at...

11/09/2019 - 22:30

New data show non-inferiority of efficacy for subcutaneous formulation of CT-P13 (biosimilar infliximab) to intravenous formulation of CT-P13 in people with rheumatoid arthritis

Celltrion Healthcare today announced data, at the American College of Rheumatology (ACR) annual meeting, from a study further investigating the efficacy, pharmacokinetics and safety, including immunogenicity, of CT-P13 SC over a one-year treatment period and after switching from CT-P13 IV to CT-P13 SC in people with rheumatoid arthritis (RA).1 A previous study demonstrated the non-inferiority ...

Celltrion Healthcare today announced data, at the American College of Rheumatology (ACR) annual meeting, from a study further investigating the efficacy, pharmacokinetics and safety, including immunogenicity, of CT-P13 SC over a one-year treatment period and after switching from CT-P13 IV to CT-P13 SC in people with rheumatoid arthritis (RA).1 A previous study demonstrated the non-inferiority ...


11/09/2019 - 22:30

New Data on Filgotinib in Rheumatoid Arthritis (RA) Demonstrate Durable Efficacy and Safety Profile

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the companies’ clinical research program evaluating filgotinib, an investigational, oral, selective JAK1 inhibitor, in adults with moderately-to-severely active RA. The data demonstrate durable efficacy and safety results with filgotinib across multiple RA patient populatio...

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the companies’ clinical research program evaluating filgotinib, an investigational, oral, selective JAK1 inhibitor, in adults with moderately-to-severely active RA. The data demonstrate durable efficacy and safety results with filgotinib across multiple RA patient populatio...


10/20/2019 - 01:29

 Vertex Announces Reimbursement of Cystic Fibrosis Medicines SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) for Eligible Patients Ages 12 and Older, and ORKAMBI® (lumacaftor/ivacaftor) in Children Ages 2 to 5, With Certain CFTR Mutations in Australia

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) is reimbursed in Australia for people with cystic fibrosis (CF) ages 12 years and older who are homozygous for the F508del mutation or who have one copy of the F508del mutation and another responsive residual function (RF) mutation in the cystic fibrosis transmembrane conductan...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) is reimbursed in Australia for people with cystic fibrosis (CF) ages 12 years and older who are homozygous for the F508del mutation or who have one copy of the F508del mutation and another responsive residual function (RF) mutation in the cystic fibrosis transmembrane conductan...


10/19/2019 - 06:30

EURid Launches New Eligibility Criteria

The top-level internet domain .eu is the eighth largest country code extension on the internet and, as of October 2019, we have more than 3.6 million registrations spread out across Europe. Since its launch in 2006, only companies and individuals residing within the EU and EEA member states have been eligible to register the .eu domain name. However, striving to meet the needs of an ever-chang...

The top-level internet domain .eu is the eighth largest country code extension on the internet and, as of October 2019, we have more than 3.6 million registrations spread out across Europe. Since its launch in 2006, only companies and individuals residing within the EU and EEA member states have been eligible to register the .eu domain name. However, striving to meet the needs of an ever-chang...

11/10/2019 - 05:09

MetLife Wins ACORD Leadership Awards

Stephen Barnham, Asia’s Chief Information Officer, and Sourav Shah, Senior Digital Product Manager in Australia, have both been awarded the ACORD Leadership Award in the individual category. The prestigous annual awards held by the Association for Cooperative Operations Research and Development (ACORD), an international non-profit insurance standards organization, recognises outstanding achiev...

Stephen Barnham, Asia’s Chief Information Officer, and Sourav Shah, Senior Digital Product Manager in Australia, have both been awarded the ACORD Leadership Award in the individual category. The prestigous annual awards held by the Association for Cooperative Operations Research and Development (ACORD), an international non-profit insurance standards organization, recognises outstanding achiev...


10/21/2019 - 00:01

New subcutaneous formulation of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) shows positive Phase 1 results for the treatment of IBD in data presented at UEG Week Barcelona 2019

Celltrion Healthcare today announced new data from a Phase 1 pivotal study to evaluate the pharmacokinetics (PK), efficacy and safety of CT-P13 SC compared to the CT-P13 IV formulation in people with inflammatory bowel disease (IBD). Results presented at UEG Week 2019 in Barcelona, Spain demonstrated non-inferiority of CT-P13 SC compared to CT-P13 IV in the PK primary endpoint at pre-dose leve...

Celltrion Healthcare today announced new data from a Phase 1 pivotal study to evaluate the pharmacokinetics (PK), efficacy and safety of CT-P13 SC compared to the CT-P13 IV formulation in people with inflammatory bowel disease (IBD). Results presented at UEG Week 2019 in Barcelona, Spain demonstrated non-inferiority of CT-P13 SC compared to CT-P13 IV in the PK primary endpoint at pre-dose leve...


10/21/2019 - 00:00

ADX Group Announces IPO Progress, New Cyber Security Offerings

ADX Group (“ADX”), owner and operator of online business services, online entertainment, and consumer electronics, announced today that the company’s progress towards its initial public offering (IPO) has advanced. In comments the day before the company’s 11th annual Autumn Conference, ADX Founder Mr. Steven M. Renner said, “ADX has formally engaged independent auditors to commence a pre-IPO a...

ADX Group (“ADX”), owner and operator of online business services, online entertainment, and consumer electronics, announced today that the company’s progress towards its initial public offering (IPO) has advanced. In comments the day before the company’s 11th annual Autumn Conference, ADX Founder Mr. Steven M. Renner said, “ADX has formally engaged independent auditors to commence a pre-IPO a...

Partners